bpc-157 immunogenicity risks fda The Pharmacology of Longevity: Peptide Edition (Part 1) The current discourse around FDA
Description
Ready for your B12 injection
2014;9(11):e112737
While that is an opinion, it reflects a growing sentiment that doctors stepping outside the bounds of evidence-based medicine with peptides are leaving themselves exposed to lawsuits
In a different study, the results showed a change in bacterial genera with age and a reduction in the numbers Bacteroides and Bifidobacteria in the elderly group
